256 patienter i alderen 16- 91 år blev randomiseret til behandling, og fik mindst én dosis af forsøgsmedicinen.
Two hundred and fifty-six patients, ranging from 16 to 91 years in age, were randomised to treatment and received at least one dose of study medication.